Volume 12, Issue 2 (3-2022)
3 2022, 12(2): 60-72 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Abdi M, Parizad B, Foroughi S, Fallahi B, Karami-Zadeh K. Evaluation of cerebral venous thrombosis risk following oral contraceptive use: A case report and update.. 3 2022; 12 (2) :60-72
URL: http://ndhj.lums.ac.ir/article-1-315-en.html
URL: http://ndhj.lums.ac.ir/article-1-315-en.html
Abstract: (1755 Views)
Background and Objectives: The aim of the present study was to report a case of cerebral venous thrombosis (CVT) folowing consumption of the oral contraceptive pills with high estrogen levels.
Case Report: A 35-year-old woman presenting a headache was diagnosed with thrombosis in the upper sagittal, sigmoid and transverse veins, by CT SCAN, MRI and MRV of the brain.
Conclusion: The chance of cerebral venous thrombosis in women taking combined oral contraceptive pills with higher estrogen levels increases in the presence of risk factors such as hypertension, hyperlipidemia, coagulation problems, infection, obesity and migraine.
Case Report: A 35-year-old woman presenting a headache was diagnosed with thrombosis in the upper sagittal, sigmoid and transverse veins, by CT SCAN, MRI and MRV of the brain.
Conclusion: The chance of cerebral venous thrombosis in women taking combined oral contraceptive pills with higher estrogen levels increases in the presence of risk factors such as hypertension, hyperlipidemia, coagulation problems, infection, obesity and migraine.
Type of Study: Research |
Subject:
General
Received: 2022/02/23 | Accepted: 2022/03/8 | Published: 2022/03/15
Received: 2022/02/23 | Accepted: 2022/03/8 | Published: 2022/03/15
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
